Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calmante Vitaminado is an over-the-counter (OTC) combination analgesic and vitamin supplement marketed by Laboratorios Combix in Spain. It contains acetylsalicylic acid (aspirin), caffeine, and thiamine hydrochloride (vitamin B1). Acetylsalicylic acid provides analgesic and antipyretic effects by inhibiting cyclooxygenase enzymes, while caffeine acts as an adjuvant to enhance the pain-relieving properties. Thiamine is included as a nutritional supplement. The product is indicated for the symptomatic relief of occasional mild to moderate pain, such as headaches, dental pain, menstrual pain, and muscle aches, as well as for the reduction of fever. Originally a product of Laboratorios Pérez Giménez, it was relaunched by Combix in 2022.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Calmante Vitaminado.